CIC
CGEM icon

Cornercap Investment Counsel’s Cullinan Oncology CGEM Stock Holding History

Cornercap Investment Counsel’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,491
Closed -$200K – 546
2024
Q2 		$200K Sell
11,491
-7,088
-38% -$151K 0.03% 540
2024
Q1 		$317K Sell
18,579
-139
-0.7% -$2.15K 0.05% 514
2023
Q4 		$191K Buy
18,718
+127
+0.7% +$1.13K 0.03% 537
2023
Q3 		$168K Sell
18,591
-204
-1% -$2.13K 0.03% 502
2023
Q2 		$202K Buy
18,795
+2,856
+18% +$30.3K 0.04% 510
2023
Q1 		$163K Hold
15,939
– – 0.03% 520
2022
Q4 		$168K Hold
15,939
– – 0.03% 521
2022
Q3 		$204K Buy
+15,939
New +$215K 0.04% 494

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cornercap Investment Counsel's CGEM Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of Cullinan Oncology (CGEM) in Q3 2024, closing a stake of 11,491 shares — an estimated $200K sold.

Cornercap Investment Counsel first reported a position in CGEM in Q3 2022 and held it in 8 quarters. The position peaked at $317K in Q1 2024. 137 funds tracked by Wall St. Rank hold CGEM as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining Cullinan Oncology position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 11,491 Cullinan Oncology shares in Q3 2024, an estimated $200K.
  • Cornercap Investment Counsel first reported a position in Cullinan Oncology in Q3 2022 and held it in 8 quarters.
  • Cornercap Investment Counsel's Cullinan Oncology position peaked at $317K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.